The plaintiffs argued that Johnson & Johnson's talcum powder products, like baby powder, caused them to develop ovarian cancer. This was the first trial to argue that talc in baby powder contains cancer-causing asbestos. Johnson & Johnson said in a statement it "is deeply disappointed" and "remains...
Johnson & Johnson has reported better than expected earnings for it's fourth quarter of 2018.
Business Insider reports that shares were sliding, down 1.39%.
The company's 2019 full-year guidance fell..
According to a report by Reuters, on Wednesday, Johnson and Johnson failed to persuade a Missouri trial judge to set aside a verdict awarding a record 4.69 billion dollars to 22 women who blamed their..